Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Genomic DNA at prime editing guide RNA (pegRNA)-specified loci refers to the precise chromosomal locations targeted for modification by prime editing technology [Anzalone et al., Nature 2019]. Prime editing is a versatile "search-and-replace" genome editing method that employs a fusion protein consisting of a catalytically impaired Cas9 nickase and an engineered reverse transcriptase enzyme [Anzalone et al., Nature 2019; Chen & Liu, Nat Rev Genet 2023]. The pegRNA serves a dual purpose: it guides the fusion protein to the specific genomic coordinates via its spacer sequence and provides the template for the desired genetic change through its 3' extension, which includes a primer binding site (PBS) and a reverse transcriptase template (RTT) [Anzalone et al., Nature 2019]. This target is central to the treatment of various genetic diseases, as it allows for the correction of point mutations, small insertions, or deletions without requiring double-strand breaks or exogenous donor DNA [Kantor et al., Mol Ther 2020]. By directly rewriting the genetic code at these loci, prime editing offers a high degree of precision and reduced off-target effects compared to traditional CRISPR-Cas9 systems [Anzalone et al., Nature 2019]. Therapeutic applications targeting these loci are currently being explored for conditions such as sickle cell disease, cystic fibrosis, and various metabolic disorders [Chen & Liu, Nat Rev Genet 2023].
Prime editing involves a search-and-replace mechanism where a Cas9 nickase-reverse transcriptase fusion protein uses a pegRNA to identify a target DNA site, nick one strand, and synthesize a new DNA sequence directly into the target locus using the pegRNA's 3' extension as a template [Anzalone et al., Nature 2019].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genomic DNA at prime editing guide RNA (pegRNA)-specified loci (pegRNA-DNA locus).